Cardiac function and aminoterminal pro-brain natriuretic peptide levels in liver-transplanted cirrhotic patients

Clinical Transplantation

Volumn 26, Issue 1, 2012, Pages 111-116

  Bernal, Vanesa ^a   Pascual, Isaac ^a   Lanas, Angel ^a,b,c   Esquivias, Paula ^b,c   Piazuelo, Elena ^b,c   Garcia Gil, Francisco A ^d   Lacambra, Isaac ^a   Simon, Miguel A ^a  

^a University Hospital Lozano Blesa   (Spain)

^b INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Aminoterminal pro brain natriuretic peptide; Cirrhotic cardiomyopathy; Diastolic dysfunction; Left ventricular hypertrophy; Liver transplantation

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE MASS; HEART SIZE; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY;

ADULT; AGED; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84856685341     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01438.x     Document Type: Article

References (30)

1. Lee SS. Cardiac abnormalities in liver cirrhosis. West J Med 1989: 151: 530.
2. Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996: 24: 451.
3. Finucci G, Desideri A, Sacerdoti D et al. Left ventricular diastolic function in liver cirrhosis. Scand J Gastroenterol 1996: 31: 279.
4. Pozzi M, Carugo S, Boari G et al. Evidence of functional and structural cardiac abnormalies in cirrhosis patients with and without ascites. Hepatology 1997: 26: 1131.
5. Therapondos G, Flapan AD, Dollinger MM, Garden OJ, Plevris JN, Hayes PC. Cardiac function after orthotopic liver transplantation and the effects of immnunosuppresion: a prospective randomized trial comparing cyclosporine (Neoral) and tacrolimus. Liver Transpl 2002: 8: 690.
6. Acosta F, De la Morena G, Villegas M et al. Evaluation of cardiac function before and after liver transplantation. Transplant Proc 1999: 31: 2369.
7. Torregrosa M, Aguade S, Dos L et al. Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol 2005: 42: 68.
8. Krishnaswamy P, Lubien E, Clopton P et al. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 2001: 111: 274.
9. Hammerer-Lercher A, Neubauer E, Müller S, Pachinger O, Puschendorf B, Mair J. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta 2001: 310: 193.
10. Yildiz R, Tildirim B, Karincaoglu M, Harputluoglu M, Hilmioglu F. Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients. J Gastroenterol Hepatol 2005: 20: 1115.
11. La Villa G, Romanelli RG, Raggi VC et al. Plasma levels of brain natriuretic peptide in patients with cirrhosis. Hepatology 1992: 16: 156.
12. Henriksen JH, Gotze JP, Fuglsang S et al. Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. Gut 2003: 52: 1511.
13. Remme WJ, Swedberg K. The task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology. Eur Heart J 2001: 22: 1527.
14. Missbichler A, Hawa G, Woloszczuk W, Schmal N, Hartter E. Enzymimmunoassays für proBNP Fragmente (8-29) und (32-57). J Lab Med 1999: 23: 241.
15. Dickstein K, Cohen-Solal A, Filippatos G et al. The task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Eur Heart J 2008: 29: 2388.
16. Aurigemma GP, Gaasch WH. Clinical practice. Diastolic heart failure. N Engl J Med 2004: 351: 1097.
17. Inserte J, Perello A, Agullo L et al. Left ventricular hypertrophy in rats with biliary cirrhosis. Hepatology 2003: 38: 589.
18. Lunseth JH, Olmstead EG, Forks G, Abboud F. A study of heart disease in one hundred eight hospitalized patients dying with portal cirrhosis. Arch Intern Med 1958: 102: 405.
19. Wong F, Siu S, Liu P, Blendis LM. Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis? Clin Sci 2001: 101: 621.
20. Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection and prognosis. Circulation 2000: 102: 470.
21. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990: 322: 1561.
22. Liu H, Lee S. What happens to cirrhotic cardiomyopathy after liver transplantation? Hepatology 2005: 42: 1203.
23. Johnston SD, Morris JK, Cramb R, Gunson BK, Neuberger J. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation 2002: 73: 901.
24. Adams KF, Lindenfeld J, Arnold JMO et al. HFSA 2006 comprehensive heart failure practice guideline. J Card Fail 2006: 12: e1.
25. Hunt SA, Abraham WT, Chin MH et al. American College of Cardiology/American Heart Association (ACC/AHA) 2005 Guideline Update for the diagnosis and management of chonic heart failure in the Adult. Circulation 2005: 112: e154.
26. Appleton CP, Hurst RT, Lee KS, Reuss C, Hentz JG. Long-term cardiovascular risk in the orthotopic liver transplantation population. Liver Transpl 2006: 12: 352.
27. Ordonez-Llanos J, Collinson PO, Christenson RH. Amino-terminal pro-B-type natriuretic peptide: analytic considerations. Am J Cardiol 2008: 101: 9A.
28. Zbròg Z, Szuflet A, Rybinska A et al. NT-proBNP plasma levels and echocardiographic assessment of cardiac function in patients after renal transplantation. Kardiol Pol 2007: 65: 345.
29. Piano MR. Alcoholic cardiomyopathy. Chest 2002: 121: 1638.
30. Clerico A, Fontana M, Zyw L, Passino C, Emdin M. Comparison of the diagnostic accuracy of BNP and NT-proBNP Immunoassays in chronic and acute heart failure: a systematic review. Clin Chem 2007: 53: 813.